1. López-Cobo, Sheila, Fuentealba, Jaime R, Gueguen, Paul, Saitakis, Michael, Amigorena, Sebastian. . SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors. In Cancer discovery, 14, 120-141. doi:10.1158/2159-8290.CD-22-1350. https://pubmed.ncbi.nlm.nih.gov/37934001/
2. Padeken, Jan, Methot, Stephen P, Gasser, Susan M. 2022. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. In Nature reviews. Molecular cell biology, 23, 623-640. doi:10.1038/s41580-022-00483-w. https://pubmed.ncbi.nlm.nih.gov/35562425/
3. Xie, Liangliang, Lin, Lang, Huang, Shihai, Shi, Deshun, Li, Xiangping. 2018. Inhibition of Suv39H1 enhances transgenic IFNα-2b gene expression in Bcap-37 cells. In Animal biotechnology, 30, 358-365. doi:10.1080/10495398.2018.1500373. https://pubmed.ncbi.nlm.nih.gov/30179066/
4. Fang, Lan, Hao, Yun, Yu, Haihong, Qin, Huan-Long, Wang, Ping. 2023. Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity. In Cancer cell, 41, 1118-1133.e12. doi:10.1016/j.ccell.2023.05.005. https://pubmed.ncbi.nlm.nih.gov/37267951/
5. Yao, Luyan, He, Funan, Zhao, Quanyi, Zhou, Bingying, Wang, Li. 2023. Spatial Multiplexed Protein Profiling of Cardiac Ischemia-Reperfusion Injury. In Circulation research, 133, 86-103. doi:10.1161/CIRCRESAHA.123.322620. https://pubmed.ncbi.nlm.nih.gov/37249015/
6. Liu, Jixuan, Luo, Qian, Zhao, Haoran, Guo, Baofeng, Zhang, Ling. 2024. Comprehensive gene set enrichment and variation analyses identify SUV39H1 as a potential prognostic biomarker for glioblastoma immunorelevance. In Computational and structural biotechnology journal, 23, 4161-4176. doi:10.1016/j.csbj.2024.11.016. https://pubmed.ncbi.nlm.nih.gov/39640533/
智鼠故事 
